Predicting Alzheimer disease with β‐amyloid imaging: Results from the Australian imaging, biomarkers, and lifestyle study of ageing

Cited by (222)

Items 101–200 of 222

1. Klotho allele status is not associated with Aβ and APOE ε4–related cognitive decline in preclinical Alzheimer's disease
   Tenielle Porter, Samantha C. Burnham, Lidija Milicic, Greg R. Savage, Paul T. Maruff, Yen Ying Lim, David J. Ames, Colin Louis Masters, Ralph Nigel Martins, Stephanie Ruth Rainey‐Smith et al. · 2019 · Neurobiology of Aging
2. Sensitivity of a Preclinical Alzheimer’s Cognitive Composite (PACC) to amyloid β load in preclinical Alzheimer’s disease
   Lisa Bransby, Yen Ying Lim, David J. Ames, Christopher James Fowler, Joanne Roberston, Karra Harrington, Peter Jeffrey Snyder, Victor L. Villemagne, Olivier Salvado, Colin Louis Masters et al. · 2019 · Journal of Clinical and Experimental Neuropsychology
3. Dendritic Spine Remodeling and Synaptic Tau Levels in PS19 Tauopathy Mice
   Walker, Courtney K., Greathouse, Kelsey M., Boros, Benjamin D., Poovey, Emily H., Clearman, Kelsey R., Ramdas, Raksha, Muhammad, Hamad M., Herskowitz, Jeremy H. · 2021 · Neuroscience
4. Central and Peripheral Immune Dysregulation in Posttraumatic Stress Disorder: Convergent Multi-Omics Evidence
   Diana L. Núñez-Ríos, José Jaime Martínez‐Magaña, Sheila T. Nagamatsu, Diego Andrade-Brito, Diego A. Forero, Carlos A. Orozco, Janitza L. Montalvo‐Ortiz · 2022 · Biomedicines
5. Transgenic Mouse Models as Tools for Understanding How Increased Cognitive and Physical Stimulation Can Improve Cognition in Alzheimer’s Disease
   Amy L. Shepherd, Tracy D. Zhang, Ariel Zeleznikow-Johnston, Anthony John Hannan, Emma L. Burrows · 2018 · Brain Plasticity
6. Cerebral Amyloid Angiopathy, Alzheimer’s Disease and MicroRNA: miRNA as Diagnostic Biomarkers and Potential Therapeutic Targets
   J. Weldon Furr, Diego Morales‐Scheihing, Bharti Manwani, Juneyoung Lee, Louise D. McCullough · 2019 · NeuroMolecular Medicine
7. Extensive memory testing improves prediction of progression to MCI in late middle age
   Daniel E. Gustavson, Jeremy A. Elman, Mark E. Sanderson‐Cimino, Carol E. Franz, Matthew S. Panizzon, Amy J. Jak, Chandra A. Reynolds, Michael Churton Neale, Michael J. Lyons, William S. Kremen · 2020 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
8. Amyloid-beta plasma and cerebrospinal fluid biomarkers in aged dogs with cognitive dysfunction syndrome
   Ioanna Stylianaki, Zoe S. Polizopoulou, Alexandros M. Theodoridis, Georgia Koutouzidou, Rania D. Baka, Nikolaos G. Papaioannou · 2020 · Journal of Veterinary Internal Medicine
9. Imaging amyloidopathy in Parkinson disease and parkinsonian dementia syndromes
   Kirk A. Frey, Myria Petrou · 2015 · Clinical and Translational Imaging
10. β-Amyloid and Tau Imaging in Chronic Traumatic Brain Injury
    Amelia J. Hicks, Jennie Louise Ponsford, Gershon Spitz, Vincent Doré, Natasha Krishnadas, CAROLINE MAY ROBERTS, Christopher Cleon Rowe · 2022 · Neurology
11. Spatiotemporal Oscillatory Patterns During Working Memory Maintenance in Mild Cognitive Impairment and Subjective Cognitive Decline
    Noelia Serrano, David López‐Sanz, Ricardo Bruña, Pilar Garcés, Inmaculada Concepción Rodríguez‐Rojo, Alberto Marcos, David Prada Crespo, Fernando Maestú · 2019 · International Journal of Neural Systems
12. Tau PET positivity predicts clinically relevant cognitive decline driven by Alzheimer’s disease compared to comorbid cases; proof of concept in the ADNI study
    Konstantinos Ioannou, Marco Bucci, Antonios Tzortzakakis, Irina Savitcheva, Agneta K. Nordberg, Konstantinos Chiotis, Alzheimer’s Disease Neuroimaging Initiative · 2024 · Molecular Psychiatry
13. Cognitive gene risk profile for the prediction of cognitive decline in presymptomatic Alzheimer’s disease
    Tenielle Porter, Victor L. Villemagne, Greg R. Savage, Lidija Milicic, Yen Ying Lim, Paul T. Maruff, Colin Louis Masters, David J. Ames, Ashley Ian Bush, Ralph Nigel Martins et al. · 2018 · Personalized Medicine in Psychiatry
14. Biomarkers and Tools for Predicting Alzheimer’s Disease in the Preclinical Stage
    Tao-Ran Li, Qin Zhao Yang, Xiaochen Hu, Ying Han · 2021 · Current Neuropharmacology
15. Connectome-derived diffusion characteristics of the fornix in Alzheimer's disease
    Rodrigo Dennis Perea, Jennifer S. Rabin, Megan G. Fujiyoshi, Taylor E. Neal, Emily E. Smith, Koene R. A. Van Dijk, Trey Hedden · 2018 · NeuroImage Clinical
16. Plasma adiponectin levels predict cognitive decline and cortical thinning in mild cognitive impairment with beta-amyloid pathology
    Keun You Kim, Junghee Ha, Minae Kim, So Yeon Cho, Hyunjeong Kim, Eosu Kim, Alzheimer’s Disease Neuroimaging Initiative · 2022 · Alzheimer s Research & Therapy
17. Amyloid Imaging With 11C-PIB in Patients With Cognitive Impairment in a Clinical Setting
    Julio Francisco Jiménez-Bonilla, Ignacio Banzo, María de Arcocha-Torres, R. Quirce, I. Martínez‐Rodríguez, Pascual Sánchez‐Juan, JOSE MANUEL CARRIL · 2015 · Clinical Nuclear Medicine
18. Performance on the Cogstate Brief Battery Is Related to Amyloid Levels and Hippocampal Volume in Very Mild Dementia
    Yen Ying Lim, Victor L. Villemagne, Simon Matthew Laws, Robert H. Pietrzak, David J. Ames, Christopher James Fowler, Stephanie Ruth Rainey‐Smith, Peter Jeffrey Snyder, Pierrick Bourgeat, Ralph Nigel Martins et al. · 2016 · Journal of Molecular Neuroscience
19. The effect of preclinical Alzheimer's disease on age-related changes in intelligence in cognitively normal older adults
    Karra Harrington, Christa Dang, Yen Ying Lim, David J. Ames, Simon Matthew Laws, Robert H. Pietrzak, Stephanie Ruth Rainey‐Smith, Joanne S. Robertson, Christopher C. Rowe, Olivier Salvado et al. · 2018 · Intelligence
20. Added value of amyloid PET in individualized risk predictions for MCI patients
    Ingrid S. van Maurik, Laura M. van der Kall, Arno de Wilde, Femke H. Bouwman, Philip Scheltens, Bart N.M. van Berckel, Johannes Hans Berkhof, Wiesje M. van der Flier, Alzheimer’s Disease Neuroimaging Initiative · 2019 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
21. Alzheimer’s Disease Polygenic Scores Predict Changes in Episodic Memory and Executive Function Across 12 Years in Late Middle Age
    Daniel E. Gustavson, Chandra A. Reynolds, Timothy J. Hohman, Angela Lee Jefferson, Jeremy A. Elman, Matthew S. Panizzon, Michael Churton Neale, Mark W. Logue, Michael J. Lyons, Carol E. Franz et al. · 2022 · Journal of the International Neuropsychological Society
22. Added diagnostic value of cerebrospinal fluid biomarkers for differential dementia diagnosis in an autopsy-confirmed cohort
    Niemantsverdriet, Ellis, Feyen, Bart F.E., Le Bastard, Nathalie, Martin, Jean-Jacques, Goeman, Johan, De Deyn, Peter Paul, Bjerke, Maria, Engelborghs, Sebastiaan · 2018 · Journal of Alzheimer s Disease
23. Longitudinal cognitive decline in mild cognitive impairment subjects with early amyloid-β neocortical deposition
    Andrea Ciarmiello, Elisabetta Giovannini, Mattia Riondato, Giampiero Giovacchini, Valerio Duce, Ornella Ferrando, Marina De Biasi, Chiara Passera, Elena Carabelli, Antonio Mannironi et al. · 2019 · European Journal of Nuclear Medicine and Molecular Imaging
24. The Relationship between Amyloid Deposition, Neurodegeneration, and Cognitive Decline in Dementia
    Rik R. Vandenberghe · 2014 · Current Neurology and Neuroscience Reports
25. Attitudes to Alzheimer's disease testing of Australian general practice patients: a cross-sectional questionnaire-based study
    Parker John Magin, Laura Juratowitch, Janet S Dunbabin, Patrick McElduff, Susan M. Goode, Amanda Tapley, Dimity C Pond · 2015 · International Journal of Geriatric Psychiatry
26. Structural MRI and Amyloid PET Imaging for Prediction of Conversion to Alzheimer's Disease in Patients with Mild Cognitive Impairment: A Meta-Analysis
    Eun Hyun Seo, Woon Yeong Park, Il Han Choo · 2017 · Psychiatry Investigation
27. Magnetic resonance evidence of increased iron content in subcortical brain regions in asymptomatic Alzheimer's disease
    Qixiang Lin, Syed Salman Shahid, Antoine Hone‐Blanchet, Shuai Huang, Junjie Wu, Aditya Singh Bisht, David W. Loring, Felicia C. Goldstein, Allan I. Levey, Bruce Crosson et al. · 2023 · Human Brain Mapping
28. Biomarkers for the diagnosis of Alzheimer's disease in clinical practice: an Italian intersocietal roadmap
    Giovanni Battista Frisoni, Daniela Perani, Stefano Bastianello, Gaetano Bernardi, Corinna Porteri, Marina Boccardi, Stefano Francesco Cappa, Marco Trabucchi, Alessandro Padovani · 2017 · Neurobiology of Aging
29. Biomarkers and Tools for Predicting Alzheimer's Disease in the Preclinical Stage
    Taoran Li, Qin Zhao Yang, Xiaochen Hu, Ying Han · 2022 · Kölner Universitäts PublikationsServer (Universität zu Köln)
30. Gender-specific relationship between thigh muscle and fat mass and brain amyloid-β positivity
    Sung Hoon Kang, Kyung Hyun Lee, Yoosoo Chang, Yeong Sim Choe, Jun Pyo Kim, Hyemin Jang, Hee Young Shin, Hee Jin Kim, Seong‐Beom Koh, Duk Lyul Na et al. · 2022 · Alzheimer s Research & Therapy
31. Physical activity and brain amyloid beta: A longitudinal analysis of cognitively unimpaired older adults
    Michael G Slee, Stephanie Ruth Rainey‐Smith, Victor L. Villemagne, James D. Doecke, Hamid Reza Sohrabi, Kevin Taddei, David J. Ames, Vincent Doré, Paul T. Maruff, Simon Matthew Laws et al. · 2023 · Alzheimer s & Dementia
32. Immunotherapy in Alzheimer’s disease: focusing on the efficacy of gantenerumab on amyloid-β clearance and cognitive decline
    Ali Azargoonjahromi · 2024 · Journal of Pharmacy and Pharmacology
33. Autonomic Cardiac Function in Preclinical Alzheimer’s Disease
    Claudia Yang Santos, Jason T. Machan, Wen‐Chih Wu, Peter Jeffrey Snyder · 2017 · Journal of Alzheimer s Disease
34. Trajectory of the MAPT-PACC-Preclinical Alzheimer Cognitive Composite in the Placebo Group of a Randomized Control Trial: Results from the MAPT Study: Lessons for Further Trials
    Jagadish Kumar Chhetri, Philipe de Souto Barreto, Christelle Cantet, Matteo Cesari, Nicola Coley, Sandrine Andrieu, Bruno J. Vellas · 2018 · The Journal of Prevention of Alzheimer s Disease
35. Increasing empathic concern relates to salience network hyperconnectivity in cognitively healthy older adults with elevated amyloid-β burden
    Tiffany E. Chow, Christina R. Veziris, Renaud La Joie, Alex J. Lee, Jesse A. Brown, Jennifer S. Yokoyama, Katherine P. Rankin, Joel H. Kramer, Bruce L. Miller, Gil Dan Rabinovici et al. · 2022 · NeuroImage Clinical
36. Neuroimaging biomarkers: a critical review of their role in neurological disease diagnosis and management
    Nitu L. Wankhede, Sushruta Koppula, Payal D. Umare, Mohit D. Umare, Sanket K. Lokhande, Brijesh Gulabrao Taksande, Aman Babanrao Upaganlawar, Milind Janrao Umekar, Spandana Rajendra Kopalli, Mayur Bhimrao Kale · 2025 · Brain Disorders
37. The preclinical amyloid sensitive composite to determine subtle cognitive differences in preclinical Alzheimer’s disease
    Alice Hahn, Young Ju Kim, Hee Jin Kim, Hyemin Jang, Hanna Cho, Seong Hye Choi, Byeong Chae Kim, Kyung Won Park, Duk Lyul Na, Juhee Chin et al. · 2020 · Scientific Reports
38. Exploring the significance of lipids in Alzheimer's disease and the potential of extracellular vesicles
    Huaqi Su, Colin Louis Masters, Ashley Ian Bush, Kevin Jeffrey Barnham, Gavin E. Reid, Laura J. Vella · 2023 · PROTEOMICS
39. A Pragmatic, Investigator-Driven Process for Disclosure of Amyloid PET Scan Results to ADNI-4 Research Participants
    Claire M. Erickson, Jason H. Karlawish, Joshua D. Grill, Kristin A. Harkins, Susan M. Landau, Mónica Rivera Mindt, Ozioma C. Okonkwo, Ronald Carl Petersen, Paul S. S Aisen, Michael Walter Weiner et al. · 2024 · The Journal of Prevention of Alzheimer s Disease
40. Antemortem Prediction of Braak Stage
    Jesper O.E. Carlson, Margaret Gatz, Nancy L. Pedersen, Caroline Graff, Inger Nennesmo, Anna-Karin Lindström, Lotte Gerritsen · 2015 · Journal of Neuropathology & Experimental Neurology
41. Enhanced Association of Tau Pathology and Cognitive Impairment in Mild Cognitive Impairment Subjects with Behavior Symptoms
    Xinting Ge, Alzheimer’s Disease Neuroimaging Initiative, Yuchuan Qiao, Jiyoon Choi, Rema Raman, John M. Ringman, Yonggang Shi · 2022 · Journal of Alzheimer s Disease
42. Quantile regression to characterize solanezumab effects in Alzheimer's disease trials
    Yun‐Fei Chen, Xiwen Ma, Karen L. Sundell, Karla Alaka, Kory J. Schuh, Joel Raskin, Robert A. Dean · 2016 · Alzheimer s & Dementia Translational Research & Clinical Interventions
43. Longitudinal Trajectories in Cortical Thickness and Volume Atrophy: Superior Cognitive Performance Does Not Protect Against Brain Atrophy in Older Adults
    Samantha L. Gardener, Michael Weinborn, Hamid Reza Sohrabi, James D. Doecke, Pierrick Bourgeat, Stephanie Ruth Rainey‐Smith, Kaikai Shen, Jürgen Fripp, Kevin Taddei, Paul T. Maruff et al. · 2021 · Journal of Alzheimer s Disease
44. A Comparison of Cross-Sectional and Longitudinal Methods of Defining Objective Subtle Cognitive Decline in Preclinical Alzheimer’s Disease Based on Cogstate One Card Learning Accuracy Performance
    Shehroo B. Pudumjee, Emily S. Lundt, Sabrina M. Albertson, Mary M. Machulda, Walter K. Kremers, Clifford R. Jack, David S. Knopman, Ronald Carl Petersen, Michelle M. Mielke, Nikki H. Stricker · 2021 · Journal of Alzheimer s Disease
45. Sensory impairment and beta‐amyloid deposition in the Baltimore longitudinal study of aging
    Lekha V. Yesantharao, Yurun Cai, Jennifer A. Schrack, Alden L. Gross, Hang Wang, Murat Bilgel, Ryan James Dougherty, Eleanor Marie Simonsick, Luigi Ferrucci, Susan M. Resnick et al. · 2023 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
46. A gallium(III) Schiff base-curcumin complex that binds to amyloid-β plaques
    Jaclyn L. Lange, David J. Hayne, Peter D. Roselt, Catriona McLean, Jonathan Michael White, Paul S. Donnelly · 2016 · Journal of Inorganic Biochemistry
47. Learning deficit in cognitively normal APOE ε4 carriers with LOW β‐amyloid
    Yen Ying Lim, Jenalle E. Baker, Andrea Mills, Loren Bruns, Christopher James Fowler, Jürgen Fripp, Stephanie Ruth Rainey‐Smith, David J. Ames, Colin Louis Masters, Paul T. Maruff · 2021 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
48. Rare forms of cerebral amyloid angiopathy: pathogenesis, biological and clinical features of CAA-ri and iCAA
    Benedetta Storti, Maria Magdalena Gabriel, Stefan Sennfält, Isabella Canavero, Nicola Rifino, Laura Gatti, Anna Bersano · 2023 · Frontiers in Neuroscience
49. Microglial responses partially mediate the effect of Aβ on cognition in Alzheimer's disease
    Lasse Stensvig Madsen, Rola Ismail, Peter Parbo, Pernille Louise Kjeldsen, Jeppe L. Schaldemose, Kim Vang Hansen, Hanne Gottrup, Joel Aanerud, Simon Fristed Eskildsen, David James Brooks · 2024 · Alzheimer s & Dementia
50. Diagnostic Utility of Integrated11C-Pittsburgh Compound B Positron Emission Tomography/Magnetic Resonance for Cerebral Amyloid Angiopathy: A Pilot Study
    Yan Zhong Chang, Jiajin Liu, Liang You Wang, Xin Li, Zhenjun Wang, Mu Lin, Wei Jin, Mingwei Zhu, Baixuan Xu · 2021 · Frontiers in Aging Neuroscience
51. Magnetic Resonance Imaging of Vascular Contributions to Cognitive Impairment and Dementia
    Nawaf Yassi, Patricia M. Desmond, Colin Louis Masters · 2016 · Journal of Molecular Neuroscience
52. Multiple markers contribute to risk of progression from normal to mild cognitive impairment
    Jennifer S. Rabin, Taylor E. Neal, Hannah E. Nierle, Sietske A.M. Sikkes, Rachel F. Buckley, Rebecca England Amariglio, Kathryn V. Papp, Dorene M. Rentz, Aaron P. Schultz, Keith A. Johnson et al. · 2020 · NeuroImage Clinical
53. Will PET Amyloid Imaging Lead to Overdiagnosis of Alzheimer Dementia?
    Jacob G. Dubroff, Ilya M. Nasrallah · 2015 · Academic Radiology
54. SPON1 Is Associated with Amyloid-β and APOE ε4-Related Cognitive Decline in Cognitively Normal Adults
    Shane Fernandez, Samantha C. Burnham, Lidija Milicic, Greg R. Savage, Paul T. Maruff, Madeline Peretti, Hamid Reza Sohrabi, Yen Ying Lim, Michael Weinborn, David J. Ames et al. · 2021 · Journal of Alzheimer s Disease Reports
55. Vestibular Function and Beta-Amyloid Deposition in the Baltimore Longitudinal Study of Aging
    Rebecca J. Kamil, Murat Bilgel, Dean Foster Wong, Susan M. Resnick, Yuri Agrawal · 2018 · Frontiers in Aging Neuroscience
56. Independent effect of body mass index variation on amyloid-β positivity
    Sung Hoon Kang, Jong Hyuk Kim, Yoosoo Chang, Bo Kyoung Cheon, Yeong Sim Choe, Hyemin Jang, Hee Jin Kim, Seong‐Beom Koh, Duk Lyul Na, Kyunga Kim et al. · 2022 · Frontiers in Aging Neuroscience
57. Amyloid β Deposition and Glucose Metabolism On the Long-Term Progression of Preclinical Alzheimer’s Disease
    Shizuo Hatashita, Daichi Wakebe · 2019 · Future Science OA
58. Evaluation of Toxic Amyloid β42 Oligomers in Rat Primary Cerebral Cortex Cells and Human iPS-derived Neurons Treated with 10-Me-Aplog-1, a New PKC Activator
    Kazuma Murakami, Mayuko Yoshimura, Shota Nakagawa, Toshiaki Kume, Takayuki Kondo, Haruhisa Inoue, Kazuhiro Irie · 2020 · International Journal of Molecular Sciences
59. Alzheimer's disease research progress in Australia: The Alzheimer's Association International Conference Satellite Symposium in Sydney
    Claire E. Sexton, Kaarin Jane Anstey, Filippo Baldacci, Christopher J. Barnum, Anna M. Barron, Kaj Blennow, Henry Brodaty, Samantha C. Burnham, Fanny M. Elahi, Jürgen Götz et al. · 2021 · Alzheimer s & Dementia
60. Imago Mundi, Imago AD, Imago ADNI
    Victor L. Villemagne, Seong Yoon Kim, Christopher Cleon Rowe, Takeshi Iwatsubo · 2014 · Alzheimer s Research & Therapy
61. The Translational Journey of Brain β-Amyloid Imaging
    Gil Dan Rabinovici · 2015 · JAMA Neurology
62. Quantitative Brain Amyloid Measures Predict Time-to-Progression from Amnestic Mild Cognitive Impairment to Alzheimer’s Disease
    Sung-Min Jun, Heeyoung Kim, B. Kim, B. Yoo, Won Gu Lee, Alzheimer's Disease Neuroimaging Initiative · 2019 · Journal of Alzheimer's Disease
63. Machine Learning for Alzheimer’s Disease and Related Dementias
    Marc Modat A, David M. Cash, Liane S. Canas, Martina Bocchetta, Sebastien Ourselin A · 2023 · Neuromethods
64. EEG Data Analysis Techniques for Precision Removal and Enhanced Alzheimer’s Diagnosis: Focusing on Fuzzy and Intuitionistic Fuzzy Logic Techniques
    Mario Versaci, Fabio La Foresta · 2024 · Signals
65. Activation of Tyrosine Phosphorylation Signaling in Erythrocytes of Patients with Alzheimer’s Disease
    Cinzia Mallozzi, Alessio Crestini, Carmen D’Amore, Paola Piscopo, M Cappella, Federica Perrone, Giuseppina Talarico, Giuseppe Bruno, Nicola Vanacore, Annamaria Confaloni · 2020 · Neuroscience
66. Intrinsic functional connectivity, CSF biomarker profiles and their relation to cognitive function in mild cognitive impairment
    Silke Matura, Jan Köhler, Andreas Reif, Fabian Fußer, Tarik Karakaya, Monika Scheibe, Felix Ehret, Daniel Hartmann, Jun‐Suk Kang, Christoph Mayer et al. · 2019 · Acta Neuropsychiatrica
67. Molecular Imaging of Extrapyramidal Movement Disorders
    Kirk A. Frey · 2016 · Seminars in Nuclear Medicine
68. Distinguishing Alzheimer’s Disease Patients and Biochemical Phenotype Analysis Using a Novel Serum Profiling Platform: Potential Involvement of the VWF/ADAMTS13 Axis
    Jay S. Hanas, James Randolph Sanders Hocker, Christian A. Vannarath, Megan R. Lerner, Scott G. Blair, Stan A. Lightfoot, Rushie J. Hanas, J.R. Couch, Linda Ann Hershey · 2021 · Brain Sciences
69. Amyloid-PET imaging offers small improvements in predictions of future cognitive trajectories
    Sarah F. Ackley, Eleanor Hayes‐Larson, Willa D. Brenowitz, Kaitlin N. Swinnerton, Dan Mungas, Evan M. Fletcher, Baljeet Singh, Rachel A. Whitmer, Charles S DeCarli, M. Maria Glymour · 2021 · NeuroImage Clinical
70. Progressive impairments in executive function in the APP/PS1 model of Alzheimer's disease as measured by translatable touchscreen testing
    Amy L. Shepherd, Jeremiah K. H. Lim, Vickie H. Y. Wong, Ariel Zeleznikow-Johnston, Leonid P. Churilov, Christine T. O. Nguyen, Bang Viet Bui, Anthony John Hannan, Emma L. Burrows · 2021 · Neurobiology of Aging
71. Association of mid-life cardiovascular risk with biomarkers of Alzheimer's disease, neurodegeneration, and white matter hyperintensities: Heart SCORE brain study
    Anum Saeed, Yue-Fang Chang, Justin Swanson, Michael Vu, Mark E. Mapstone, Victor L. Villemagne, Beth Ellen Snitz, Sarah K. Royse, Hong-tian Wang, Brian J. Lopresti et al. · 2025 · Journal of Alzheimer s Disease Reports
72. Prädiktion der Alzheimer-Demenz
    Frank Jessen, Richard C. Dodel · 2014 · Der Nervenarzt
73. Diagnostic role of 11C-Pittsburgh compound B retention patterns and glucose metabolism by fluorine-18-fluorodeoxyglucose PET/CT in amnestic and nonamnestic mild cognitive impairment patients
    Julio Francisco Jiménez-Bonilla, Ignacio Banzo, María de Arcocha-Torres, R. Quirce, I. Martínez‐Rodríguez, Carmen Lavado-Pérez, Zully Bravo-Ferrer, Eloy Rodríguez‐Rodríguez, Pascual Sánchez‐Juan, JOSE MANUEL CARRIL · 2016 · Nuclear Medicine Communications
74. Distinct Neural Correlates of Executive Function by Amyloid Positivity and Associations with Clinical Progression in Mild Cognitive Impairment
    Hyung‐Jun Yoon, Seung-Gon Kim, Sang Hoon Kim, Il Han Choo, Sang Hag Park, Eun Hyun Seo, Alzheimer’s Disease Neuroimaging Initiative · 2019 · Yonsei Medical Journal
75. A brief history of Aβ imaging
    Ann D. Cohen, Victor L. Villemagne · 2025 · Alzheimer s & Dementia
76. Aβ misfolding in blood plasma measured by immuno‐infrared‐sensor as an age‐independent risk marker of Alzheimer's disease
    Tobias Möllers, Hannah R. Stocker, Laura Perna, Andreas Nabers, Dan Rujescu, Annette M. Hartmann, Bernd Holleczek, Ben Schöttker, Klaus Bernhard Gerwert, Hermann Brenner · 2021 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
77. Use of Amyloid Positron-Emission Tomography to Diagnose Alzheimer's Disease in Clinical Practice in South Korea: Expert Recommendations
    Kee Hyung Park, Seong Hye Choi, YongSoo Shim, Young Chul Youn, Dong Won Yang, SangYun Kim · 2025 · Journal of Clinical Neurology
78. In vivo tau is associated with change in memory and processing speed, but not reasoning, in cognitively unimpaired older adults
    Sharon Sanz Simon, Eleanna M. L. Varangis, Seonjoo Lee, Yian Gu, Yunglin Gazes, Qolamreza Ray Razlighi, Christian Georg Habeck, Yaakov Stern · 2023 · Neurobiology of Aging
79. COMT val158met is not associated with Aβ-amyloid and APOE ε4 related cognitive decline in cognitively normal older adults
    Tenielle Porter, Samantha C. Burnham, Lidija Milicic, Greg R. Savage, Paul T. Maruff, Hamid Reza Sohrabi, Madeline Peretti, Yen Ying Lim, Michael Weinborn, David J. Ames et al. · 2019 · IBRO Reports
80. Utility of Molecular and Structural Brain Imaging to Predict Progression from Mild Cognitive Impairment to Dementia
    Martin J. Lan, Robert Todd Ogden, Dileep J.S. Kumar, Yaakov Stern, Ramin V. Parsey, Gregory H. Pelton, Harry Rubin‐Falcone, Gnanavalli Pradhaban, Francesca Zanderigo, Jeffrey Morris Miller et al. · 2017 · Journal of Alzheimer s Disease
81. Reply: Cortical tau pathology: a major player in fibre-specific white matter reductions in Alzheimer's disease?
    R. Mito, D. Raffelt, Thijs Dhollander, D. Vaughan, Jacques-Donald Tournier, Olivier Salvado, A. Brodtmann, C. Rowe, V. Villemagne, A. Connelly · 2018 · Brain : a journal of neurology
82. In vivo microstructural heterogeneity of white matter lesions in Alzheimer’s disease using tissue compositional analysis of diffusion MRI data
    Remika Mito, Thijs Dhollander, Ying Xia, David A. Raffelt, Olivier Salvado, Leonid P. Churilov, Christopher Cleon Rowe, Amy G. Brodtmann, Victor L. Villemagne, Alan Connelly · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
83. Highly sensitive β-amyloid1–42 oligomer aptamer-based assay via dual cyclic amplifications of three-way catalytic hairpin assembly and palindrome polymerase reaction
    Zihao Yin, Xiaoju Liu, Shunmei Li, Ruo Yuan, Yun Xiang · 2024 · Sensors and Actuators B Chemical
84. CSF Aβ40 Levels Do Not Correlate with the Clinical Manifestations of Alzheimer’s Disease
    Jesús García Castro, Helena Méndez del Sol, Olaia Rodríguez Fraga, María Hernández-Barral, Soledad Serrano-López, Ana Frank García, Ángel Martín Montes · 2022 · Neurodegenerative Diseases
85. A Single Baseline Amyloid Positron Emission Tomography Could Be Sufficient for Predicting Alzheimer’s Disease Conversion in Mild Cognitive Impairment
    Il Han Choo, Ari Chong, Ji Yeon Chung, Jung‐Min Ha, Yu Yong Choi, Hoowon Kim · 2022 · Psychiatry Investigation
86. Aβ Imaging in Aging, Alzheimer’s Disease and Other Neurodegenerative Conditions
    Victor L. Villemagne, Michelle T. Fodero‐Tavoletti, Paul A Yates, Colin Louis Masters, Christopher Cleon Rowe · 2014 · Springer eBooks
87. Simple Quantification of Surface Uptake in F-18 Florapronol PET/CT Imaging for the Validation of Alzheimer’s Disease
    Do-Hoon Kim, Junik Son, Chae Moon Hong, Ho‐Sung Ryu, Shin Young Jeong, Sang‐Woo Lee, Jaetae Lee · 2022 · Diagnostics
88. Cardiovascular Risk as a Moderator of the Relationship Between Plasma Alzheimer Disease Biomarkers and Cognitive Status
    Angelina Kirilova Kancheva, Donald M. Lyall, Kamen A. Tsvetanov, Ivana Kirilova Kancheva, Kalliopi Mavromati, Ivan G. Koychev, Benjamin Tari, Daniela Jaime García, Lynne Hughes, Joanna Marguerite Wardlaw et al. · 2025 · Journal of the American Heart Association
89. Decoding Alzheimer's Disease With Depression: Molecular Insights and Therapeutic Target
    Zekun Li, Hongmin Guo, Yihao Ge, Xiaohan Li, Fang Dong, Feng Zhang · 2025 · Journal of Cellular and Molecular Medicine
90. The Ethics of Biomarker-Based Preclinical Diagnosis of Alzheimer’s Disease
    Alexander Kurz, Nicola T. Lautenschlager · 2018 · Neuromethods
91. Imaging-Based Biomarkers in Neurological Diseases-A Critical Review
    Mayur Bhimrao Kale, Nitu L. Wankhede, Brijesh Gulabrao Taksande, Aman Upaganlawar, Milind Janrao Umekar, Sushruta Koppula, Spandana Rajendra Kopalli · 2023 · Preprints.org
92. How does type 2 diabetes modify the risk of Alzheimer's disease?
    Greg Trevor Sutherland, A. Chen, H‐T. Nguyen‐Hao, Hamish D. Mundell, E. Aladyeva, Markus J Hofer, Oscar Harari, S. M. Twigg · 2026 · Alzheimer s & Dementia
93. Amyloid Deposition Is Greater in Cerebral Gyri than in Cerebral Sulci with Worsening Clinical Diagnosis Across the Alzheimer’s Disease Spectrum
    Lucas M. Walden, Alzheimer’s Disease Neuroimaging Initiative, Song Hu, Anant Madabhushi, Jeffrey W. Prescott · 2021 · Journal of Alzheimer s Disease
94. Safety of Disclosing Amyloid Imaging Results to MCI and AD Patients
    Carl Taswell, Cheryl Donohue, Maree Mastwyk, Andrea Louey, Jacqueline Giummarra, Joanne S. Robertson, David Darby, Colin Master, Christopher Cleon Rowe · 2023 · Brainiacs Journal of Brain Imaging And Computing Sciences
95. Genomic insights into the etiology of Alzheimer's disease: a review
    Reitz · 2014 · Advances in Genomics and Genetics
96. The Neurochemistry of Alzheimer’s Disease: One of the Most Common Causes of Reduced Capability in the Adult Population
    Kaj Blennow, Henrik Zetterberg · 2022 · International perspectives on aging
97. Correlation of Global and Regional Amyloid Burden by 18F-Florbetaben PET/CT With Cognitive Impairment Profile and Severity
    Francisco José Pena Pardo, Ana María García Vicente, Mariano Amo‐Salas, Beatriz Mondéjar Marín, Santiago Navarro Muñoz, Piedad García Hortelano, Ignacio Rueda Medina, Eloy García Pérez, Amanda Padilla Bermejo, Víctor Manuel Poblete García et al. · 2022 · Clinical Nuclear Medicine
98. A Comparative Study of [F-18] Florbetaben (FBB) PET Imaging, Pathology, and Cognition between Normal and Alzheimer Transgenic Mice
    Ngeemasara Thapa, Y. Jeong, Hyeon Kang, Go-E Choi, H. Yoon, Do-Young Kang · 2019 · Biomedical Science Letters
99. Current and Developing Methods for Diagnosing Alzheimer's Disease
    Stephanie Jane Fuller, Nicholas Carrigan, Hamid Reza Sohrabi, Ralph Nigel Martins · 2019 · Wiley eBooks
100. Longitudinal Association of Mid-Life Ten Year Cardiovascular Disease Risk Score with Brain Biomarkers of Alzheimer’s Disease, Neurodegeneration and White Matter Hyper Intensities in Cognitively Unimpaired Older Adults: Heart SCORE Brain Study
     Anum Saeed, Yue‐Fang Chang, Justin Swanson, Michael Vu, Mark E. Mapstone, Victor L. Villemagne, Beth Ellen Snitz, Sarah K. Royse, Brian J. Lopresti, Howard Jay Aizenstein et al. · 2024 · medRxiv